Society Endorsed Books

The following books are endorsed and/or written by members of SBMT:

Author: Dr. Antonio Di Ieva is a Neurosurgeon and Associate Professor (Clinical Senior Lecturer) at Macquarie University Hospital in Sydney, Australia. He has published 80 peer-reviewed articles and won 5 international awards in Neurosurgery and Neurosciences. Dr Di Ieva is a peer-reviewer in 15 international journals and a member of the editorial board of 9 journals, including Frontiers in Neuroanatomy.

Editor: Paul W. Glimcher is a neuroeconomist, neuroscientist, psychologist, economist, scholar, and entrepreneur. He is one of the foremost researchers focused on the study of human behavior and decision-making, and is known for his central role in founding and developing the field of neuroeconomics which takes an interdisciplinary approach to understanding how humans make decisions.

Author: Dr. Kewal K. Jain has Culled together excerpts from a wide range of writings by on biotechnology topics as they relate to disorders of the nervous system, Applications of Biotechnology in Neurology covers a variety of applications for those working in life sciences and the pharmaceutical sciences, particularly those developing diagnostics and therapeutics for the nervous system.

Author: Dr. George Paxinos has paved the way for future neuroscience research as the first to produce a three-dimensional (stereotaxic) framework for placement of electrodes and injections in the brain of experimental animals, now an international standard.

Author: Dr. George Paxinos has paved the way for future neuroscience research as the first to produce a three-dimensional (stereotaxic) framework for placement of electrodes and injections in the brain of experimental animals, now an international standard.

Author: Dr. Wes Ashford is a leading researcher and clinician involved with the study of Cognitive Disorders. He is the founder of MedFile.com, a site servicing the mental health care industry.

Author: Dr. Kuldip Sidhu, a well known scientist in stem cell research. His team has produced a human embryonic stem cell (hESC) line without the use of any animal products. The breakthrough eliminates the risk of animal-to-human contamination in potential stem cell therapy treatments.